Literature DB >> 26193839

Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry.

Lydia M Young1, Rachel A Mahood, Janet C Saunders, Ling-Hsien Tu, Daniel P Raleigh, Sheena E Radford, Alison E Ashcroft.   

Abstract

The precise molecular mechanisms by which different peptides and proteins assemble into highly ordered amyloid deposits remain elusive. The fibrillation of human amylin (also known as islet amyloid polypeptide, hIAPP) and the amyloid-beta peptide (Aβ-40) are thought to be pathogenic factors in Type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), respectively. Amyloid diseases may involve co-aggregation of different protein species, in addition to the self-assembly of single precursor sequences. Here we investigate the formation of heterogeneous pre-fibrillar, oligomeric species produced by the co-incubation of hIAPP and Aβ-40 using electrospray ionisation-ion mobility spectrometry-mass spectrometry (ESI-IMS-MS)-based methods. Conformational properties and gas-phase stabilities of amyloid oligomers formed from hIAPP or Aβ40 alone, and from a 1 : 1 mixture of hIAPP and Aβ40 monomers, were determined and compared. We show that co-assembly of the two sequences results in hetero-oligomers with distinct properties and aggregation kinetics properties compared with the homo-oligomers present in solution. The observations may be of key significance to unravelling the mechanisms of amyloid formation in vivo and elucidating how different sequences and/or assembly conditions can result in different fibril structures and/or pathogenic outcomes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26193839      PMCID: PMC4626081          DOI: 10.1039/c5an00865d

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  66 in total

1.  Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic.

Authors:  Aleksandra Velkova; Marianna Tatarek-Nossol; Erika Andreetto; Aphrodite Kapurniotu
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

2.  Widespread amyloid deposition in transplanted human pancreatic islets.

Authors:  Gunilla T Westermark; Per Westermark; Christian Berne; Olle Korsgren
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

Review 3.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.

Authors:  Per Westermark; Arne Andersson; Gunilla T Westermark
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

4.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

Authors:  Summer L Bernstein; Nicholas F Dupuis; Noel D Lazo; Thomas Wyttenbach; Margaret M Condron; Gal Bitan; David B Teplow; Joan-Emma Shea; Brandon T Ruotolo; Carol V Robinson; Michael T Bowers
Journal:  Nat Chem       Date:  2009-07       Impact factor: 24.427

5.  Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts.

Authors:  K J Potter; A Abedini; P Marek; A M Klimek; S Butterworth; M Driscoll; R Baker; M R Nilsson; G L Warnock; J Oberholzer; S Bertera; M Trucco; G S Korbutt; P E Fraser; D P Raleigh; C B Verchere
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity.

Authors:  Carole Anne De Carufel; Phuong Trang Nguyen; Sabrina Sahnouni; Steve Bourgault
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

7.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.

Authors:  Jed J W Wiltzius; Stuart A Sievers; Michael R Sawaya; David Eisenberg
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

8.  Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor.

Authors:  Chris T Middleton; Peter Marek; Ping Cao; Chi-cheng Chiu; Sadanand Singh; Ann Marie Woys; Juan J de Pablo; Daniel P Raleigh; Martin T Zanni
Journal:  Nat Chem       Date:  2012-03-11       Impact factor: 24.427

9.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

Authors:  Justin M Nussbaum; Stephan Schilling; Holger Cynis; Antonia Silva; Eric Swanson; Tanaporn Wangsanut; Kaycie Tayler; Brian Wiltgen; Asa Hatami; Raik Rönicke; Klaus Reymann; Birgit Hutter-Paier; Anca Alexandru; Wolfgang Jagla; Sigrid Graubner; Charles G Glabe; Hans-Ulrich Demuth; George S Bloom
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

10.  Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.

Authors:  Igor F Tsigelny; Leslie Crews; Paula Desplats; Gideon M Shaked; Yuriy Sharikov; Hideya Mizuno; Brian Spencer; Edward Rockenstein; Margarita Trejo; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

View more
  19 in total

Review 1.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

2.  Analysis of Proline Substitutions Reveals the Plasticity and Sequence Sensitivity of Human IAPP Amyloidogenicity and Toxicity.

Authors:  Zachary Ridgway; Charles Eldrid; Alexander Zhyvoloup; Aisha Ben-Younis; Daeun Noh; Konstantinos Thalassinos; Daniel P Raleigh
Journal:  Biochemistry       Date:  2020-01-30       Impact factor: 3.162

3.  Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly.

Authors:  Maria Bakou; Kathleen Hille; Michael Kracklauer; Anna Spanopoulou; Christina V Frost; Eleni Malideli; Li-Mei Yan; Andrea Caporale; Martin Zacharias; Aphrodite Kapurniotu
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

4.  Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly.

Authors:  Yong Xu; Roberto Maya-Martinez; Nicolas Guthertz; George R Heath; Iain W Manfield; Alexander L Breeze; Frank Sobott; Richard Foster; Sheena E Radford
Journal:  Nat Commun       Date:  2022-02-24       Impact factor: 17.694

5.  Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.

Authors:  Xinwei Ge; Ye Yang; Yunxiang Sun; Weiguo Cao; Feng Ding
Journal:  ACS Chem Neurosci       Date:  2018-02-09       Impact factor: 4.418

6.  Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease.

Authors:  Michal Baram; Yoav Atsmon-Raz; Buyong Ma; Ruth Nussinov; Yifat Miller
Journal:  Phys Chem Chem Phys       Date:  2016-01-28       Impact factor: 3.676

7.  Profiling the Serum Protein Corona of Fibrillar Human Islet Amyloid Polypeptide.

Authors:  Emily H Pilkington; Ove J R Gustafsson; Yanting Xing; Juan Hernandez-Fernaud; Cleidi Zampronio; Aleksandr Kakinen; Ava Faridi; Feng Ding; Paul Wilson; Pu Chun Ke; Thomas P Davis
Journal:  ACS Nano       Date:  2018-05-16       Impact factor: 15.881

Review 8.  The application of ion-mobility mass spectrometry for structure/function investigation of protein complexes.

Authors:  Gili Ben-Nissan; Michal Sharon
Journal:  Curr Opin Chem Biol       Date:  2017-11-09       Impact factor: 8.822

9.  Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly.

Authors:  Rodrigo Gallardo; Matthew G Iadanza; Yong Xu; George R Heath; Richard Foster; Sheena E Radford; Neil A Ranson
Journal:  Nat Struct Mol Biol       Date:  2020-09-14       Impact factor: 15.369

10.  Quantitative interrogation of protein co-aggregation using multi-color fluorogenic protein aggregation sensors.

Authors:  Yulong Bai; Wang Wan; Yanan Huang; Wenhan Jin; Haochen Lyu; Qiuxuan Xia; Xuepeng Dong; Zhenming Gao; Yu Liu
Journal:  Chem Sci       Date:  2021-05-20       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.